This article was first published on Orbex Forex Trading Blog.
- -
This content is synced from the rightful owners. Copyright on text and images belong to the original source.
- -

johnson & johnson stocks

Shares in leading US pharmaceutical firm Johnson & Johnson are trading higher by around half a percent pre-market on Monday. Stock prices in the company have traded higher across the month,. Prices have extended gains despite a reported Q2 earnings miss.

7% Sales Drop

Johnson & Johnson reported earnings per share of $1.36 over the June quarter. This undershot expectations of a $1.49 EPS. The company posted sales of $18.3 billion over the quarter. This marked a 10.8% decline in global sales versus the same period last year. Total net income was lower by 34.6% over the quarter, moving down to $3.62 billion.

Looking at the breakdown of the company’s businesses, the consumer health division posted revenues of $2.88 billion in Q2. This is a 7% decline on the same quarter a year prior. However, sales in the US were seen rising by 1.3% over the period.

Specific Impact From COVID-19

The company cited the downward drag from the COVID-19 pandemic as the main cause of its loss of earnings...

To keep reading this article, please navigate to: Orbex Forex Trading Blog.